Faircloth Cobb (banjohour4)

019, p = 0.023, p = 0.012, p = 0.044 and p = 0.036, respectively). Bilateral uterine arterial occlusion using a temporary uterine tourniquet had no negative effects on pregnancy outcomes. A temporary uterine tourniquet may be an effective method for reducing the amount of perioperative bleeding in patients with multiple, large-sized myomas located close to vascular structures. A temporary uterine tourniquet may be an effective method for reducing the amount of perioperative bleeding in patients with multiple, large-sized myomas located close to vascular structures. The aim of this study was to evaluate the efficacy, side-effects and continuation rate of the desogestrel-progestin-only-pill (POP) in postpartum and post-abortive Turkish women its relation with breast-feeding. In this prospective multicentric study women who delivered (or had surgical abortion) and wanted to receive POP for contraception were recruited to the study. The follow-up visits were scheduled at 3rd, 6th and 9th months. Overall 7468 women (66.5% postpartum, 33.5% post-abortive) participated in the study. According to the previous visit, the percentage of women who came for a follow-up visit at 3rd, 6th and 9th month was 944(12.6%), 406(43%) and 121(29.8%) respectively. Out of the 7468 women recruited only 6% continued with the method at the end of the 9th month. There was a statistically significant increase in Hb level at the 3rd month when compared to the initial values. The incidence of breastfeeding at all visits was between 54.8% and 68.4%. Oligomenorrhea, spotting and headache were the three leading side-effects. There was no pregnancy among the patients who were followed up. This study demonstrates that POP is an effective postpartum and post-abortive contraceptive method that has no negative impact on breast-feeding and the change in bleeding patterns is the most common side-effect. However, the possible causes of low contraceptive maintenance rates need to be investigated. This study demonstrates that POP is an effective postpartum and post-abortive contraceptive method that has no negative impact on breast-feeding and the change in bleeding patterns is the most common side-effect. However, the possible causes of low contraceptive maintenance rates need to be investigated. The diagnosis of endometrial cancer is made by biopsy sampling with pathological analysis, but it is extremely important to make an accurate diagnosis in order to plan the specific treatment, and we suggest that HE4 in the endometrial tissue and in serum could be tools to make the diagnosis more precise. Our prospective study compared patients with endometrial cancer against non-endometrial cancer ones, matched with several variables. Selleck TGF-beta inhibitor The inclusion criteria were females older than 18 years old that accepted to participate in the research study but that had never underwent surgery for other oncological pathologies, whether for ovarian, colon, cervical carcinoma or uterine sarcoma, and none of them had received preoperative chemo or radiotherapy; moreover, they could not have any severe renal or liver pathology. All of them had hysterectomy surgery and the endometrium was studied by a pathologist who compared the regular staining with HE4-antibody staining, in addition, there were collected the serum samples previous to the surgery. Suggest bad correlation between the tissue HE4 in patients with and without carcinoma, however, the serum HE4 is statistically significant in the diagnosis of endometrial carcinoma (median EC= 123.1 U, median NE=64.67 U, p=0.002), although the CA125 level is not significant (p=0.208). Compared to previous studies our results are quite different in the pathological side, but the serum conclusions are positive and very hopeful as the tumor marker HE4 seems to be able to diagnose endometrial cancer. Compared to pre